AI can address health inequities, but cannot replace human touch: Union MoS Health Anupriya Patel

Speaking at the AI Impact Summit in the national capital, Patel asserted that India's governance model positions AI as an enabler and force multiplier, bringing the country closer to the goals of inclusivity and health equity.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3wjVESA
via IFTTT

Read More

29 vitamin-mineral FDC drugs under review for possible ban over 'irrational' tag

A looming ban on twenty-nine vitamin and mineral combination drugs has sparked a heated debate. Initially flagged as irrational by an expert panel in 2015, these products are now being re-evaluated by a specialized sub-committee. Before any final ruling, the companies will be given a chance to defend their products.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/eWhaIyb
via IFTTT

Read More

Lupin signs supply deal to launch antidepressant in Canada

Drug firm Lupin has partnered with Spektus Pharma. They will commercialise the antidepressant DeslaFlex in Canada. This collaboration combines Lupin's Canadian presence with Spektus's formulation expertise. It aims to offer patients more personalized care for Major Depressive Disorder. The deal strengthens Lupin's central nervous system portfolio. Lupin shares saw a slight increase on Monday.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/kMS69A4
via IFTTT

Read More

Alkem Labs' Chakan facility gets six observations in USFDA inspection, no data integrity issues

Alkem Laboratories announced its subsidiary Enzene Biosciences received a Form 483 from the USFDA. The inspection at the Chakan manufacturing unit resulted in six procedural observations. The company highlighted zero observations related to data integrity. Enzene is preparing its response to the USFDA within the given timeline. Corrective actions are also being initiated.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/uRrOng6
via IFTTT

Read More

Govt looks to provide access to AI resources to medical students: Official

The government plans to give medical students access to e-books and AI tools. This initiative will begin with 57 government medical colleges in smaller towns and rural areas. The aim is to improve students' skills by providing better access to digital and AI-powered learning materials. The program will gradually expand to include private colleges later.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/PVv2AMH
via IFTTT

Read More

Adven Biotech says it's India's first homeopathic brand to get NABL certification

Adven Biotech achieves a significant milestone as India's first homeopathy brand to earn NABL certification. This accreditation underscores India's commitment to global healthcare standards in the Ayush sector. The certification validates Adven's quality control and testing laboratories, aligning with Prime Minister Modi's vision for Ayush. It aims to boost confidence and expand the global acceptance of Indian homeopathy.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/zTj9iAE
via IFTTT

Read More

GST rejig marks key shift towards making cancer care affordable, AIIMS researchers says

AIIMS researchers highlight recent GST reforms, including tax exemptions on cancer drugs and medical equipment, aiming to make cancer care more affordable. Increased taxation on tobacco products is also noted as a positive step for public health and revenue generation for cancer initiatives.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/g7EB8Ql
via IFTTT

Read More